Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Healthcare Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Bullboard (TSX:ONC)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by ENEMENEMYNEMOon Jun 12, 2024 2:36pm

RE:RE:RE:RE:RE:RE:RE:Multiple thoughts.

Mehhhh.  I was expecting more
40
Discussion
Comment by Azzak34on Jun 12, 2024 2:27pm

RE:RE:RE:RE:RE:RE:Multiple thoughts.

How's BCT working out Nemo? 
44
Discussion
Comment by Azzak34on Jun 12, 2024 2:25pm

RE:RE:RE:RE:RE:RE:Multiple thoughts.

The reason I asked is because you continually tell us all what you've done after the fact!!  Forecast entry and exit for 3 stocks you've recently bought in to so we can assess your ...more  
49
Discussion
Post by fasttrack5on Jun 12, 2024 2:18pm

From USA newsgroup

https://stocks.apple.com/A33Eu25M4Qo-pK1fHgRB38Q
75
Comment by ENEMENEMYNEMOon Jun 12, 2024 2:14pm

RE:RE:RE:RE:RE:Multiple thoughts.

Want some marshmallows?
36
Discussion
Comment by Quentin30on Jun 12, 2024 2:14pm

RE:RE:RE:RE:RE:Multiple thoughts.

No-one carea about my portfolio, is that irony..?? as you asked me for entry and exit points... I told you already... I bought in heavy at the end of October 2023... liquidated half my ONCY, and was ...more  
49
Discussion
Comment by Noteableon Jun 12, 2024 12:01pm

RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals

June 12, 2024 - Goldman Sachs 45th Global Healthcare Conference - J&J is one drugmaker that’s likely poised to participate in any expectred M&A rebound, according to Nauman Shah, global ...more  
85
Discussion
Comment by Noteableon Jun 12, 2024 11:53am

RE:RE:Big pharma is set to keep signing bigger deals in 2024

June 12, 2024 - Dealmakers predict that a rebound in public transactions will come soon.  “Big Pharma still has the same challenges and the only way for them to solve this is through BD ...more  
66
Discussion
Comment by Azzak34on Jun 12, 2024 11:28am

RE:RE:RE:RE:Multiple thoughts.

First, no one cares what you do with your portfolio. I asked you to give me an entry and exit on Crispy weeks ago and you dodged the question.  Second, no one is arguing that ONCY could, maybe ...more  
96
Discussion
Comment by Quentin30on Jun 12, 2024 10:47am

RE:RE:RE:Multiple thoughts.

I don't want to be CEO... thanks for the suggestion but I'm quite content in my role thanks... My point is simply that Matt failed to reduce time to market, by running all the additional ...more  
71
Discussion
Comment by canadafanon Jun 12, 2024 10:33am

RE:RE:Multiple thoughts.

Q30. with all your brilliance, you must have a PhD. you should apply for the CEO or perhaps you are just another FUDster taking portions of statements out of context. You are correct , the additional ...more  
149
Discussion
Comment by Quentin30on Jun 12, 2024 10:07am

RE:Multiple thoughts.

Actually Canadafan, all we know is that ONCY told us that the FDA suggested they find biomarkers... THIS was not a command, not an instruction, but advice... FDA granted ONCY a SPA for a Phase III in ...more  
79
Discussion
Comment by canadafanon Jun 11, 2024 8:06pm

RE:RE:RE:RE:Inflation Reduction Act (IRA) boosts biological drugs

Nice capulation of the upcoming & changing trends in cancer care. Oncolytics biotech, fit into 4 of the 4, categories. Yes Onc has been around 20+ years. however the technology & science to ...more  
146
Discussion
Comment by Noteableon Jun 11, 2024 7:00pm

RE:RE:RE:Inflation Reduction Act (IRA) boosts biological drugs

May 14, 2024 - Recent Trends in the Global Cancer Biologics Market In recent years, the global cancer biologics market has witnessed several notable trends that have reshaped its dynamics:  ...more  
78
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities